CN103154024A - 新型n末端修饰的胰岛素衍生物 - Google Patents

新型n末端修饰的胰岛素衍生物 Download PDF

Info

Publication number
CN103154024A
CN103154024A CN2011800496891A CN201180049689A CN103154024A CN 103154024 A CN103154024 A CN 103154024A CN 2011800496891 A CN2011800496891 A CN 2011800496891A CN 201180049689 A CN201180049689 A CN 201180049689A CN 103154024 A CN103154024 A CN 103154024A
Authority
CN
China
Prior art keywords
insulin
human insulin
desb30 human
gglu
terminal
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN2011800496891A
Other languages
English (en)
Chinese (zh)
Inventor
P.马德森
P.巴尔施密特
S.哈夫伦
T.赫格-延森
T.B.克杰尔德森
C.H.菲恩博
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Novo Nordisk AS
Original Assignee
Novo Nordisk AS
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novo Nordisk AS filed Critical Novo Nordisk AS
Publication of CN103154024A publication Critical patent/CN103154024A/zh
Pending legal-status Critical Current

Links

Images

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575—Hormones
    • C07K14/62—Insulins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Diabetes (AREA)
  • Endocrinology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biophysics (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Toxicology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Obesity (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Hematology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Emergency Medicine (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Medicinal Preparation (AREA)
CN2011800496891A 2010-10-15 2011-10-14 新型n末端修饰的胰岛素衍生物 Pending CN103154024A (zh)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
EP10187706.6 2010-10-15
EP10187706 2010-10-15
US39409010P 2010-10-18 2010-10-18
US61/394,090 2010-10-18
PCT/EP2011/068019 WO2012049307A2 (en) 2010-10-15 2011-10-14 Novel n-terminally modified insulin derivatives

Publications (1)

Publication Number Publication Date
CN103154024A true CN103154024A (zh) 2013-06-12

Family

ID=43638785

Family Applications (1)

Application Number Title Priority Date Filing Date
CN2011800496891A Pending CN103154024A (zh) 2010-10-15 2011-10-14 新型n末端修饰的胰岛素衍生物

Country Status (5)

Country Link
US (1) US20140315797A1 (cg-RX-API-DMAC7.html)
EP (1) EP2627670A2 (cg-RX-API-DMAC7.html)
JP (1) JP2013540771A (cg-RX-API-DMAC7.html)
CN (1) CN103154024A (cg-RX-API-DMAC7.html)
WO (1) WO2012049307A2 (cg-RX-API-DMAC7.html)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN113646329A (zh) * 2019-03-29 2021-11-12 诺和诺德股份有限公司 葡萄糖敏感性胰岛素衍生物

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HUE032284T2 (en) 2008-03-18 2017-09-28 Novo Nordisk As Protease-stabilized, acylated insulin analogues
EP2836508B1 (en) 2012-04-11 2016-06-29 Novo Nordisk A/S Insulin formulations
AU2015349890B2 (en) * 2014-11-21 2018-08-30 Merck Sharp & Dohme Llc Insulin receptor partial agonists
CN108368163A (zh) * 2015-08-25 2018-08-03 诺和诺德股份有限公司 新型胰岛素衍生物及其医学用途
BR112018002416A2 (pt) * 2015-08-25 2018-09-18 Novo Nordisk As derivados de insulina e seus usos médicos
EP3341401A1 (en) * 2015-08-25 2018-07-04 Novo Nordisk A/S Novel insulin derivatives and the medical uses hereof
CN114656378A (zh) * 2016-05-16 2022-06-24 得克萨斯州大学系统董事会 阳离子磺酰胺氨基脂质和两亲性两性离子氨基脂质
ES2886837T3 (es) 2016-12-16 2021-12-21 Novo Nordisk As Composiciones farmacéuticas que contienen insulina
CA3071686A1 (en) 2017-08-17 2019-02-21 Novo Nordisk A/S Novel acylated insulin analogues and uses thereof
TW202039437A (zh) 2018-12-11 2020-11-01 法商賽諾菲公司 肽黏合劑
MA58093B1 (fr) 2019-12-11 2024-09-30 Novo Nordisk A/S Nouveaux analogues d'insuline et leurs utilisations

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2008145721A2 (en) * 2007-06-01 2008-12-04 Novo Nordisk A/S N-terminal modification of polypeptides for protection against degradation by aminopeptidases
WO2009022005A1 (en) * 2007-08-15 2009-02-19 Novo Nordisk A/S Insulin analogues with an acyl and alkylene glycol moiety

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ273285A (en) * 1993-09-17 1997-10-24 Novo Nordisk As Insulin derivatives and compositions thereof
AU2004261353B2 (en) 2003-08-05 2009-12-10 Novo Nordisk A/S Novel insulin derivatives
ES2435522T3 (es) * 2005-02-02 2013-12-20 Novo Nordisk A/S Derivados de insulina
CN101180081B (zh) 2005-05-25 2015-08-26 诺沃-诺迪斯克有限公司 稳定的多肽制剂
CN101541830A (zh) 2006-09-22 2009-09-23 诺沃-诺迪斯克有限公司 蛋白酶抗性的胰岛素类似物
EP2514406A1 (en) 2007-06-01 2012-10-24 Novo Nordisk A/S Spontaneously dispersible preconcentrates including a peptide drug in a solid or semisolid carrier
HUE032284T2 (en) 2008-03-18 2017-09-28 Novo Nordisk As Protease-stabilized, acylated insulin analogues
CN102149411A (zh) * 2008-09-12 2011-08-10 诺沃—诺迪斯克有限公司 酰化肽或蛋白的方法
EP2344200A2 (en) 2008-09-19 2011-07-20 Nektar Therapeutics Modified therapeutics peptides, methods of their preparation and use
CN102227213A (zh) 2008-11-28 2011-10-26 诺沃—诺迪斯克有限公司 适合于衍生化的胰岛素肽的口服施用的药物组合物
BR112012016853A2 (pt) 2010-01-12 2017-10-17 Novo Nordisk As "composições farmacêuticas para administração oral de peptídeos de insulina".

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2008145721A2 (en) * 2007-06-01 2008-12-04 Novo Nordisk A/S N-terminal modification of polypeptides for protection against degradation by aminopeptidases
WO2009022005A1 (en) * 2007-08-15 2009-02-19 Novo Nordisk A/S Insulin analogues with an acyl and alkylene glycol moiety

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
WAYNE D.KOHN等: "pI-shifted insulin analogs with extended in vivo time action and favorable receptor selectivity", 《PEPTIDES》 *
黄涛: "化学修饰胰岛素的制备、表征和生物活性", 《中国博士学位论文全文数据库工程科技I辑》 *

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN113646329A (zh) * 2019-03-29 2021-11-12 诺和诺德股份有限公司 葡萄糖敏感性胰岛素衍生物
CN113646329B (zh) * 2019-03-29 2025-12-09 诺和诺德股份有限公司 葡萄糖敏感性胰岛素衍生物

Also Published As

Publication number Publication date
US20140315797A1 (en) 2014-10-23
WO2012049307A3 (en) 2012-06-14
EP2627670A2 (en) 2013-08-21
JP2013540771A (ja) 2013-11-07
WO2012049307A2 (en) 2012-04-19

Similar Documents

Publication Publication Date Title
US20140315797A1 (en) Novel N-Terminally Modified Insulin Derivatives
ES2611007T3 (es) Análogos de insulina acilada, estabilizados frente a proteasas
ES2672770T3 (es) Derivados del péptido-1 similar al glucagón y su uso farmacéutico
JP5931857B2 (ja) 追加のジスルフィド結合を含有するインスリン誘導体
JP2020169197A (ja) 新規のアミリン及びカルシトニン受容体アゴニスト
AU2014333979B2 (en) Novel derivative of an insulin analogue
AU2006224537A1 (en) Extended GLP-1 compounds
ZA200707261B (en) Acylated GLP-1 compounds
JP2010538049A (ja) 切断型glp−1誘導体及びその治療的使用
JP2011520847A (ja) 遅効型y2及び/又はy4レセプターアゴニスト
CN102227213A (zh) 适合于衍生化的胰岛素肽的口服施用的药物组合物
CN104364262A (zh) N末端修饰的胰岛素衍生物
BR112012029248B1 (pt) Análogo de glp-1 de fórmula i ou a sua composição, análogo de glp-1 de fórmula viii ou um sal farmaceuticamente aceitável ou a composição do mesmo, composição farmacêutica e uso de um composto
JP6013330B2 (ja) 追加のジスルフィド結合を含有するヒトインスリン
TW201307381A (zh) 新穎的n-端經修飾胰島素衍生物
AU2013205270B2 (en) Protease stabilized, acylated insulin analogues
EA050089B1 (ru) Полипептиды и варианты их применения

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
RJ01 Rejection of invention patent application after publication
RJ01 Rejection of invention patent application after publication

Application publication date: 20130612